CORC

浏览/检索结果: 共16条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Solid supported ruthenium catalyst for growing single-walled carbon nanotubes with narrow chirality distribution 期刊论文
CARBON, 2022, 卷号: 193, 页码: 35-41
作者:  Zhang, Xueting;  Qian, Liu;  Yao, Xiaojing;  Zhang, Lili;  Wu, Qianru
收藏  |  浏览/下载:31/0  |  提交时间:2022/07/14
Long non-coding RNA NEAT1 inhibits oxidative stress-induced vascular endothelial cell injury by activating the miR-181d-5p/CDKN3 axis 期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 期号: 1
作者:  Yao, Jing;  Zhang, Min;  Wang, Xueting;  Qiu, Zhaohui
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
Corrigendum to "A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study" [J. Pharm 期刊论文
2019
作者:  Yao Xueting;  Song Ling;  Liu Yang;  Wang Huanhuan;  Liu Jie
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus 期刊论文
2019, 卷号: 136, 页码: 104942
作者:  Yao, Xueting;  Wu, Yiwen;  Jiang, Ji;  Chen, Xia;  Liu, Dongyang
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Development of a simple HPLC-MS/MS method to simultaneously determine teriflunomide and its metabolite in human plasma and urine: Application to clinical pharmacokinetic study of teriflunomide sodium and leflunomide 期刊论文
2019, 卷号: 33, 期号: 3, 页码: e4420
作者:  Yao, Xueting;  Liu, Yang;  Song, Ling;  Jiang, Ji;  Xiao, Fei
收藏  |  浏览/下载:14/0  |  提交时间:2020/01/03
Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects 期刊论文
2019, 卷号: 39, 期号: 7, 页码: 643-651
作者:  Yao, Xueting;  Wu, Yiwen;  Jiang, Ji;  Hu, Pei;  Liu, Dongyang
收藏  |  浏览/下载:14/0  |  提交时间:2020/01/03
A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study 期刊论文
2019, 卷号: 166, 页码: 20-29
作者:  Yao, Xueting;  Song, Ling;  Liu, Yang;  Wang, Huanhuan;  Liu, Jie
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis 期刊论文
2018, 卷号: 125, 页码: 50-60
作者:  Zeng, Fanxin;  Wen, Wei;  Cui, Weiyi;  Zheng, Wen;  Liu, Yuli
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Development of an HPLC-MS/MS method to determine janagliflozin in human plasma and urine: application in clinical study 期刊论文
2018, 卷号: 10, 期号: 17, 页码: 1439-1454
作者:  Song, Ling;  Liu, Yang;  Yao, Xueting;  Liu, Hongzhong;  Chen, Bo
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03
Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry 期刊论文
2018, 卷号: 157, 页码: 189-200
作者:  Liu, Yang;  Yao, Xueting;  Song, Ling;  Liu, Hongzhong;  Zhao, Qian
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace